Catalyst Pharmaceuticals (CPRX) Stock Price
$21.62 2%
to add to portfolio
AI Score
-
Alternative
6 -
Fundamental
8 -
Technical
5
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Catalyst Pharmaceuticals, AI stock picks, stock alerts and much more.
CPRX AI Stock Analysis
AI stock analysis for CPRX is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Catalyst Pharmaceuticals (CPRX) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Catalyst Pharmaceuticals (CPRX) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Catalyst Pharmaceuticals (CPRX), currently trading at $21.62, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About CPRX
-
Catalyst Pharmaceuticals, Inc.
-
Symbol
CPRX
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
2.6B
Similar Stocks
 |
Inovio Pharmaceuticals INO |
$2.24 0.9% |
2 |
 |
Moderna MRNA |
$35.53 5.3% |
4 |
 |
Anavex Life Sciences AVXL |
$8.35 3.8% |
6 |
 |
BridgeBio Pharma BBIO |
$36.85 0.1% |
6 |
 |
Crispr Therapeutics CRSP |
$47.91 5% |
6 |
News
CPRX Alternative Data
Web Traffic
Catalyst Pharmaceuticals receives an estimated 13051 monthly visitors to catalystpharma.com.
-
Web Traffic
13051
-
Change from Previous Month
42.7%
-
3 Month Change
30.8%
-
YoY Change
30.8%
Reddit Mentions
Catalyst Pharmaceuticals has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
News Mentions
Catalyst Pharmaceuticals was mentioned 1 times in the news yesterday.
-
News Mentions
1
-
Daily Change
66.7%
-
1 Month Change
50%
-
3 Month Change
75%
Twitter Followers
Catalyst Pharmaceuticals has 839 Twitter Followers on its main Twitter (also known as X) account.
-
Twitter Followers
839
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
9.8%
-
YoY Change
9.8%
Facebook Engagement
Catalyst Pharmaceuticals has engaged 11 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
11
-
Daily Change
8.3%
-
1 Month Change
120%
-
3 Month Change
42.1%
-
YoY Change
42.1%
Business Outlook
-
Business Outlook
100
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
CPRX Financials
CPRX Key Metrics
-
Total Revenue
$126.4M
-
Net Income
$43.9M
-
Earnings per Share
$0.37
-
Free cash flow
$72.6M
-
EBITDA
$50.9M
-
EBITDA Ratio
0.402685
-
Total Assets
$772M
CPRX 2-year Revenue & Income
CPRX 2-year Free Cash Flow
CPRX Technicals
CPRX SMA
CPRX RSI
FAQ
What's the current price of Catalyst Pharmaceuticals (CPRX) Stock?
The price of an Catalyst Pharmaceuticals (CPRX) share is $21.62.
What's the market cap of Catalyst Pharmaceuticals?
The current market cap of Catalyst Pharmaceuticals is 2.6B.
Should I buy or sell CPRX?
Catalyst Pharmaceuticals shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Catalyst Pharmaceuticals is better viewed as a hold or accumulate position while waiting for further developments.
Is Catalyst Pharmaceuticals a good investment?
The current analysis of Catalyst Pharmaceuticals' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Catalyst Pharmaceuticals' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Catalyst Pharmaceuticals (CPRX) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Catalyst Pharmaceuticals stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Catalyst Pharmaceuticals (CPRX) that investors often compare it to?
Catalyst Pharmaceuticals (CPRX) is often compared to similar stocks such as Inovio Pharmaceuticals, Moderna, Anavex Life Sciences, BridgeBio Pharma and Crispr Therapeutics.
What is the forecast for Catalyst Pharmaceuticals' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Catalyst Pharmaceuticals' stock price to be around $22.88 in 2026. Starting from the current price of $21.62, this represents a 5.8% change in price, indicating a bullish outlook for the stock.
How to buy Catalyst Pharmaceuticals (CPRX) Stock?
Catalyst Pharmaceuticals stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Catalyst Pharmaceuticals shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.